Filtering

Page: () 1 ... 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 ... 56 ()
9: Introduction to IBD-BIOM EU Project Forum
Year: 2016
Authors: Lauc G.
Crohn's Disease, Ulcerative Colitis
Files: 1
9: Nutritional aspects in IBD7th N-ECCO School
Year: 2016
Authors: Sigall-Boneh R.
ANAEMIA, ENTERAL SUPPLEMENTS
Files: 1
9: Resect 5th S-ECCO IBD Masterclass
Year: 2016
Authors: Espín Basany E.
ileocecal resection, Crohn's Disease
Files: 1
9: Superinfection1st H-ECCO IBD Masterclass
Year: 2016
Authors: Feakins R.
histopathology, CMC, C Diff
Files: 1
9: Very early onset IBD – from research to bedside ECCO'16 Amsterdam
Year: 2016
Authors: Uhlig H.
paediatric
Files: 1
9: What do IBD nurses do?3rd Basic ECCO: EduCational COurse for Industry
Year: 2016
Authors: White L.
ANTI-TNF AGENTS
Files: 1
Assessment of endoscopic activity: Clinical trials and routine practice1st ECCO Endoscopy Workshop
Year: 2016
Authors: Katsanos K.
Disease activity indices, Colonoscopy
Files: 1
DOP001: Genetic and environmental risk model to predict intestinal inflammation in asymptomatic first-degree relatives of Crohn’s disease patientsECCO'16 DOP
Year: 2016
Authors: Taylor K.
calprotectin, capsule endoscopy, Crohn's Disease, genetics
Files: 1
DOP003: Gene Expression Profiling Indicates Similar Molecular Pathways Are Active in Adult And Pediatric Ulcerative ColitisECCO'16 DOP
Year: 2016
Authors: Li K.
genetics, Ulcerative Colitis, paediatric
Files: 1
DOP004: Epigenetic control of colonic epithelial antigen processing, barrier function, and the microbiome via methyl-CpG binding domain protein 2ECCO'16 DOP
Year: 2016
Authors: Jones G.
epithelial cell, genetics, lymphocyte, microbiota, epigenetics
Files: 1
DOP007: Interleukin-10 inhibits human IFN#CHR:gamma_LOWER# and IL-17-producing T helper cells indirectly by controlling antigen-presenting cell functionECCO'16 DOP
Year: 2016
Authors: Veenbergen S.
dendritic cell, Crohn's Disease, lymphocyte, mucosal immunology
Files: 1
DOP008: Human intestinal V#CHR:delta_LOWER#2+ T-cells acquire antigen-presenting potency upon exposure to microbial phosphoantigen: modulation by mucosal inflammation and vedolizumab therapyECCO'16 DOP
Year: 2016
Authors: McCarthy N.
Crohn's Disease, Ulcerative Colitis, Lymphocyte, mucosal immunology, vedolizumab
Files: 1
DOP009: An autoimmunity-associated variant in PTPN22 protects from disease onset in mouse models of colitisECCO'16 DOP
Year: 2016
Authors: Spalinger M.
cancer in IBD, IBD, microbiota, lymphocyte, genetics
Files: 1
DOP010: Frequency and Characteristics of Infusion Reactions during Biosimilar Infliximab Treatment in Inflammatory Bowel Diseases: results from Central European nationwide cohortECCO'16 DOP
Year: 2016
Authors: Balint A.
anti-TNF agents, biosimilars, Ulcerative Colitis, Crohn's Disease, trough levels
Files: 1
DOP011: Early immunomodulator exposure and the long-term outcome of Crohn’s disease: target for changing the natural history?ECCO'16 DOP
Year: 2016
Authors: Jeuring S.
Thiopruines (AZA / MP), Crohn's Disease
Files: 1
DOP013: A 104 week mucosal healing assessment of symptomatic small bowel Crohn’s diseaseECCO'16 DOP
Year: 2016
Authors: Hall B.
anti-TNF, capsule endoscpy, Crohn's Disease, mucosal healing
Files: 1
DOP014: Nutritional optimisation of pre-surgical Crohn’s disease patients with enteral nutrition significantly decreases length of stay and need for a stomaECCO'16 DOP
Year: 2016
Authors: Patel K.
ileocecal resection, postoperative complications, preoperative management, enteral nutrition
Files: 1
Page: () 1 ... 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 ... 56 ()